Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
77.7M
-
Shares change
-
+20.1M
-
Total reported value, excl. options
-
$1.31B
-
Value change
-
+$340M
-
Put/Call ratio
-
0.19
-
Number of buys
-
91
-
Number of sells
-
-24
-
Price
-
$16.90
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q1 2018
136 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q1 2018.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77.7M shares
of 334M outstanding shares and own 23.25% of the company stock.
Largest 10 shareholders include venBio Select Advisor LLC (8.08M shares), PERCEPTIVE ADVISORS LLC (6.16M shares), BlackRock Inc. (5.78M shares), ORBIMED ADVISORS LLC (5.55M shares), FRANKLIN RESOURCES INC (5.31M shares), ACUTA CAPITAL PARTNERS, LLC (4.26M shares), FARALLON CAPITAL MANAGEMENT LLC (4.15M shares), GREAT POINT PARTNERS LLC (3.32M shares), VANGUARD GROUP INC (3.28M shares), and Consonance Capital Management LP (3.21M shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.